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Transient receptor potential channels in rat renal microcircula- Although Ang II elicits both afferent and efferent arteri-
tion: Actions of angiotensin II. olar constriction via Ang II type 1 (AT1) receptors, post-
Background. This study assessed the calcium-activating mech- receptor mechanisms mediating Ang II-induced constric-anisms mediating glomerular arteriolar constriction by angio-
tion differ between afferent and efferent arterioles [1, 2].tensin II (Ang II).
Ang II evokes membrane depolarization in afferent butMethods. Immunohistochemical and physiological studies
were carried out, using antibody against transient receptor not efferent arterioles [3]. Recent studies suggest that in
potential (TRP)-1 and an isolated perfused kidney model. afferent arterioles, Ang II elicits inositol trisphosphate
Results. Immunohistochemical experiments demonstrated (IP3)-induced calcium release (IP3CR), which rendersthat TRP-1 proteins were transcribed on both afferent and
calcium-activated chloride channels more likely to open,efferent arteriolar myocytes. In the first series of physiological
thereby inducing membrane depolarization and conse-experiments, Ang II (0.3 nmol/L) considerably constricted af-
ferent (20.2  0.9 to 14.9  0.7 m) and efferent arterioles quent activation of voltage-dependent calcium channels
(18.4  0.7 to 14.0  0.7 m). The addition of nifedipine (1 [4]. In efferent arterioles, Ang II also stimulates phos-
mol/L) restored decrements in afferent (to 20.0  0.8 m) pholipase C and calcium influx [4], but the cellular basisbut not efferent arteriolar diameters. Further administration
for this calcium entry remains to be determined.of SKF-96365 (100 mol/L), a TRP channel blocker, reversed
Receptor-stimulated currents are triggered in re-efferent arteriolar constriction (to 16.2  0.8 mol/L). In the
second group, although 2-aminoethoxydiphenyl borate (100 sponse to agonist binding to either G-protein- or tyrosine
mol/L), an inhibitor of inositol trisphosphate-induced calcium kinase-coupled receptors. Receptor-activated calcium
release (IP3CR), did not alter glomerular arteriolar diameters, channels, together with voltage-dependent or ligand-it prevented Ang II-induced afferent arteriolar constriction
operated calcium channels, form physiologically the mostand attenuated efferent arteriolar constriction (18.8  0.8 to
important calcium influx pathways, being highly diverged16.9m). Subsequent removal of extracellular calcium abol-
ished residual efferent arteriolar constriction (to 19.1 0.8m). in activation mechanisms and calcium permeability [5].
Conclusions. Our data provide evidence that Ang II elicits In the last few years, our knowledge about the molecu-
IP3CR, possibly inducing a cellular response that activates lar identity of receptor-stimulated channels has substan-voltage-dependent calcium channels on afferent arterioles. The
tially expanded. Characterization of mammalian homo-present results suggest that Ang II-induced efferent arteriolar
logs of Drosophila transient receptor potential (TRP)constriction involves IP3CR and calcium influx sensitive to
SKF-96365. proteins, which are activated following phosphoinositide
breakdown, gives an important clue for understanding
mechanisms underlying receptor-activated calcium influx.
Angiotensin II (Ang II), a potent renal vasoconstric- Although there are molecular similarities between volt-
tor, plays an important role in physiological regulation of age-dependent calcium channels and TRP channels, TRP
glomerular hemodynamics and excretory function [1, 2]. channels are gated independently of voltage because
they lack the structure of voltage-sensor [6]. TRP chan-
nels expressed on diverse cells are gated differently in
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response to either diacylglycerol, protein kinase C, theage-dependent calcium channel, cell signaling, arteriolar constriction,
cardiovascular disease, SKF-96365. increase in cytosolic calcium, or store depletion [6–10].
At least seven TRP mammalian homologs have beenReceived for publication September 12, 2001
already cloned (TRP-1 to TRP-7). Northern blot analysisand in revised form March 22, 2002
Accepted for publication March 25, 2002 reveals that TRP-1, -3 and -6 are expressed in rat kidneys
[11]. In addition, both rat TRP-3 and -6 are store-sensi- 2002 by the International Society of Nephrology
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tive [11, 12]. In the present study, we showed that TRP-1 that allowed direct microscopic visualization of renal
microvessels [15]. At this point, the kidneys were studied.proteins are transcribed in glomerular arterioles. Thus,
For the perfusion of the kidneys, the rats were againefferent arterioles provide unique experimental settings
anesthetized with ether. The right renal artery was can-to investigate the role of TRP channels in receptor-acti-
nulated by introducing the perfusion cannula throughvated calcium influx. Furthermore, the present data pro-
the mesenteric artery and across the aorta. Perfusionvide evidence that SKF-96365 (SKF), a TRP channel
with warm, oxygenated media (pH 7.4) was initiatedblocker [5, 9], inhibits calcium influx by Ang II in efferent
during this cannulation procedure. The kidney was ex-arterioles. Finally, our results suggest that TRP channels
cised and renal capsule was removed to promote theare gated independently of IP3CR on efferent arterioles.
visualization of microvessels. Then the kidney was placed
on the stage of an inverted microscope (Model T041;
METHODS Olympus), modified to accommodate a heated chamber
An antibody to rat TRP-1 and SKF (1-(beta-[3-(4- equipped with a thin siliconized glass viewing port on
the bottom surface [4].methoxy-phenyl)propoxy]-4-methoxyphenethyl)-1H-
The perfusion media consisted of Krebs-Ringer bicar-imidazole hydrochloride) were purchased from Cal-
bonate buffer containing 5 mmol/L d-glucose and a com-biochem (San Diego, CA, USA). Anti-rabbit IgG was
plement of amino acids [16]. Perfusate was provided topurchased from American Qualex (San Clement, CA,
the kidney at a constant pressure from a pressurizedUSA). Diaminobenzidine (DAB), Ang II, ryanodine and
chamber. The chamber pressure was maintained by theethylene glycol-bis-(8-aminoethyl ether)-N,N,N’,N’-tetra-
inflow of warm, hydrated gas of 95% O2-5% CO2, whichacetic acid (EGTA) were obtained from Sigma (St. Louis,
exited through an adjustable back-pressure regulatorMO, USA). 2-Aminoethoxydiphenyl borate (APB) and
(model 10BP; Fairchild Industrial Products, Winston Sa-nifedipine were provided by Ono Pharmaceuticals (Tokyo,
lem, NC, USA). Perfusion pressure measured at the levelJapan) and Bayer Co., Ltd. (Osaka, Japan), respectively.
of renal artery was maintained constant at 80 mm HgAll protocols were approved by our institutional ethical
throughout experiments to avoid pressure-induced arte-committees [13].
riolar constriction [13]. The effluent was returned to the
pressurized chamber by two rolling pumps (Masterflex,Histological study
Chicago, IL, USA).Renal tissues from Sprague-Dawley rats (Charles
Kidneys were allowed to equilibrate for at least 30River Japan, Atsugi, Kanagawa, Japan) were fixed in 4%
minutes before basal measurements were obtained. Videoparaformaldehyde in phosphate-buffered saline (PBS) at
images of the renal microvessels were obtained utilizing aroom temperature overnight, rinsed in serial concentra-
CCD video camera (model ICD-42AC; Ikegami, Tokyo,tions of sucrose solutions, and snap-frozen. Cryostat sec-
Japan) and recorded by a video cassette recorder (modeltions of 4m thickness were air-dried, rinsed in PBS, and
EVO-9850; Sony, Tokyo, Japan). One or two pair(s) ofthen immersed in 3% H2O2 in methanol for inhibition afferent and efferent arterioles were observed from each
of endogenous peroxidase and flooded with 5% bovine
kidney. To determine the vessel diameter, the video record-
albumin in PBS for inhibition of nonspecific reaction. ing was transmitted to an IBM-AT computer equipped
Rabbit anti-rat TRP-1 was used as the primary antibody, with a display board (model TARGA; Truevision, In-
and biotinylated goat anti-rabbit IgG was then applied as dianapolis, IN, USA). Vessel diameters were estimated
the secondary antibody. The following immunoreaction with an automated program custom designed to deter-
was performed using a Vectastain ABC standard kit mine the mean distance between parallel edges. The renal
(Vector Laboratories, Burlingame, CA, USA) and visu- microvessel diameters were obtained during the plateau
alized using DAB as a substrate. The second antibody of the response [13].
had been isolated by immunoaffinity chromatography In the first series of experiments, the kidneys (N  5)
and absorbed for dual labeling. Controls included omit- were initially exposed to increasing doses of Ang II from
ting the primary antibody and the primary antibody pre- 0.1 to 0.3 nmol/L [4]. In the presence of Ang II (0.3
absorbed with the purified rat TRP-1 protein [14]. nmol/L), nifedipine (1 mol/L) was administered di-
rectly to the perfusate. Finally, SKF was added directly
Physiological study to the media in a cumulative manner to achieve final
Nineteen adult male Sprague-Dawley rats (Charles concentrations of 1, 10 and 100mol/L. SKF was selected
River Japan) were utilized for induction of hydronephro- because it potently blocks calcium current through TRP
sis. The right ureter was exposed by a small abdominal channels [5, 9]. Conditioning of animals with TRP anti-
incision and ligated under ether anesthesia (Showa senses was hindered because they accumulated only in
Chemicals, Tokyo, Japan). After 8 to 10 weeks after the tubules of the kidney [14].
In the second series of experiments, the kidneys (N surgery, renal tubular atrophy had progressed to a stage
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Fig. 1. Transient receptor potential (TRP) channels in afferent (A and
B) and efferent (B) arteriolar myocytes. TRP is denoted by the brown
color. Perinuclear lucency was remarkable. The immunogenic peptide
used to generate the antibody abolished the staining (C). Magnification
200.
5) were treated with 100 mol/L of APB, an inhibitor microvascular constriction was assessed under the inhibi-
of IP3CR [17, 18]. APB was used because it most selec- tion of IP3CR and voltage-dependent calcium channels,
tively acts on IP3 receptors among the known membrane- as it may suppress the calcium release and calcium entry
permeable IP3CR blockers [18]. Thirty minutes later, in- through L-type calcium channels [20].
creasing doses of Ang II were added. Finally, the perfusate Data are expressed as means  SE. Statistical signifi-
was replaced by calcium-free media with 2 mmol/L of cance was determined by the Student t test, or analysis
EGTA, to which APB and Ang II had been added [16]. of variance (ANOVA) followed by the Newmann-Keuls
In the third series of studies (4 kidneys), ryanodine test. P values less than 0.05 were considered to be statisti-
(10 mol/L) was initially administered [19]. This dose cally significant.
of ryanodine was chosen based on our earlier results
that it prevented afferent arteriolar oscillation induced
RESULTSby BAYK-8644 (abstract; Takenaka et al, J Am Soc
As seen in Figure 1 A and B, TRP-1 proteins wereNephrol 10:388A, 1999). Subsequently, Ang II was added
immunolocalized on both afferent and efferent arteriolarin a cumulative manner to obtain concentrations of 0.1
myocytes. Vessels connecting between interlobular ar-and 0.3 nmol/L.
teries and glomeruli were considered to be afferent arte-In the fourth group (5 kidneys), basal arteriolar diame-
rioles. Vessels that arose from glomeruli and wereter was initially observed, and then nifedipine (1mol/L)
formed within the glomeruli were defined as efferentand Ang II (0.3 nmol/L) were added. Subsequently, 100
arterioles [21]. The immunogenic peptide used to gener-mol/L of APB was administered. Following the 30-
ate the antibody abolished the staining (Fig. 1C). Mesan-minute re-equilibration period, SKF was added to
gial and endothelial cells exhibited negative staining.achieve final concentrations of 1, 3, 10, 30 and 100
mol/L. The influence of SKF on Ang II-induced renal Figure 2 A-C shows that Ang II (0.3 nmol/L) con-
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Fig. 2. Representative photographs describing the effects of nifedipine and/or SKF-96365 (SKF) on angiotensin II (Ang II)-induced afferent (A-C)
and efferent (D-F ) arteriolar constriction (magnification 400).
stricted the afferent arteriole and nifedipine (1 mol/L) elicited prompt glomerular arteriolar constriction that
was sustained for at least two hours after the administra-returned afferent arteriolar diameter. Similarly, Ang II
(0.3 nmol/L)-induced efferent arteriolar constriction was tion of Ang II under our experimental condition [4].
Thus, all protocols were completed within two hoursreversed by 100 mol/L of SKF (Fig. 2 D-F). Figure 3
summarizes the effects of nifedipine and SKF on Ang following the addition of Ang II. Ang II (0.1 nmol/L)
constricted afferent (20.2  0.9 to 17.8  0.8 m, P II-induced glomerular arteriolar constriction. Ang II
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Fig. 4. Influence of 2-aminiethoxydiphenyl borate (APB) on angioten-
sin II (Ang II)-induced glomerular arteriolar constriction. Symbols are:
() afferent arterioles; () efferent arterioles. [Ca]o denotes the extra-
cellular calcium concentration. *P  0.05 vs. respective basal value.
Fig. 3. Effects of nifedipine and SKF-96365 (SKF) on angiotensin II
(Ang II)-induced glomerular arteriolar constriction. Symbols are: ()
afferent arterioles; () efferent arterioles. *P 0.05 vs. respective basal
value.
0.01, N  7) and efferent arterioles (18.4  0.7 to 17.1 
0.8 m, P 0.05, N 7). At 0.3 nmol/L, Ang II induced
further decreases in afferent (to 14.9  0.7 m, P 
0.01) and efferent arteriolar diameters (to 14.0  0.7
m, P  0.01). Subsequent administration of nifedipine
(1 mol/L) restored decrements in afferent arteriolar
diameters (to 20.0 0.8 m). SKF (10 mol/L) reversed
efferent arteriolar constriction (to 15.5  0.7 m, P 
0.05 vs. Ang II 0.3 nmol/L). At 100 mol/L, SKF further
increased efferent arteriolar diameters to 16.2  0.8 m
(P  0.01).
The influence of APB on Ang II-induced glomerular
arteriolar constriction was described in Figure 4. The
addition of APB (100 mol/L), an inhibitor of IP3CR,
did not induce any changes in either afferent or efferent
arteriolar diameters, indicating that this dose of APB
Fig. 5. Impacts of ryanodine on angiotensin II (Ang II)-induced glo-
was not too high to provoke calcium release in our exper- merular arteriolar constriction. Symbols are: () afferent arterioles;
() efferent arterioles. *P  0.05 vs. respective basal value.imental conditions [18]. APB blocked Ang II-induced
both transient (20.8  0.7 to 20.4  0.7 m; N  7) and
sustained afferent arteriolar constriction (to 20.4  0.6 efferent arterioles (18.8 0.8 to 16.9 0.9 m; P 0.05,
m). The above findings are compatible with previous N 7) in the presence of APB. Removal of extracellular
one [18], and verify that at 100 mol/L, APB was also calcium returned this efferent arteriolar diameters to
sufficient to completely inhibit IP3CR in our experimen- 19.1  0.8 m.
Figure 5 depicts the impact of ryanodine (10 mol/L)tal situation. However, Ang II (0.3 nmol/L) constricted
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Fig. 6. Angiotensin II (Ang II)-induced glomerular arteriolar constric-
tion under the inhibition of voltage-dependent calcium channels. Ang
II only temporally constricted the afferent arteriole from 21.2 to 19.0
Fig. 7. Influence of 2-aminiethoxydiphenyl borate (APB) and SKF-m in the presence of nifedipine.
96365 (SKF) on angiotensin II (Ang II)-induced efferent arteriolar
constriction. *P  0.05 vs. basal value.
on glomerular arteriolar constriction. Exposure to rya-
nodine did not alter the afferent or efferent arteriolar
Thus, the treatment with ryanodine failed to alter thediameters. In the presence of ryanodine, Ang II (0.1
arteriolar responsiveness to Ang II.nmol/L) decreased both afferent (19.4  0.6 to 17.2 
Figure 6 is representative tracings illustrating Ang II-0.7 m; P  0.01, N  6) and efferent arteriolar diame-
induced arteriolar constriction under the inhibition ofters (18.7  1.0 to 16.7  0.9 m; P  0.05, N  6). At
voltage-dependent calcium channels. Although the ad-0.3 nmol/L, Ang II caused further afferent (to 14.5 
ministration of Ang II (0.3 nmol/L) induced transient0.5 m; P  0.01) and efferent arteriolar constriction
afferent arteriolar constriction, sustained afferent arteri-(to 13.3  0.8 m; P  0.01). Our preliminary studies
olar constriction was prevented by nifedipine. However,indicated that in the presence of either APB or ryano-
Ang II elicited persistent constriction in efferent arteri-dine, afferent arterioles were constricted by membrane
oles treated with nifedipine. Because afferent arteriolesdepolarization with increasing potassium concentration
did not exhibit sustained constriction, the mean data[16], suggesting that these agents used for calcium release
regarding the actions of APB and SKF were denoteddo not interact with voltage-dependent calcium channels.
only for efferent arterioles in Figure 7. Ang II (0.3To facilitate the comparisons, the data were converted
nmol/L) constricted efferent arterioles (18.8  0.8 toto percent changes in arteriolar diameters. In control
14.8  0.8 m; P  0.01, N  7). Subsequent additioncondition, at 0.1 and 0.3 nmol/L, Ang II decreased affer-
of APB increased efferent arteriolar diameters to 16.7ent arterioles by 13  2% and 27  3%, respectively.
0.9 m (P  0.01 vs. Ang II). SKF antagonized AngIn the presence of ryanodine, 0.1 nmol/L of Ang II con-
II-induced efferent arteriolar constriction in a dose-stricted afferent arterioles by 12  2%. Ang II (0.3
dependent manner. Significant reversal of efferent arterio-nmol/L) induced 25  3% of decrements in afferent
lar constriction was achieved with 10 mol/L of SKF (toarteriolar diameters treated with ryanodine. Ang II (0.1
17.7  0.8 m; P  0.05 vs. APB). SKF (30 mol/L)nmol/L) constricted efferent arterioles by 10  2 and
returned efferent arteriolar diameters to 18.6  0.8 m.11  2% in the absence and presence of ryanodine,
Increasing doses of SKF up to 100 mol/L did not showrespectively. At 0.3 nmol/L, Ang II resulted in 26  3%
further efferent arteriolar vasodilation (to 18.8  0.9of efferent arteriolar constriction in the control state.
m). Thus, the IC50 for SKF in reversing Ang II-inducedAng II (0.3 nmol/L) elicited 29  3% of the reductions
in efferent arteriolar diameter exposed to ryanodine. efferent arteriolar constriction was 12  2 mol/L.
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release calcium in response to lower cytosolic calciumDISCUSSION
rather than ryanodine receptors, accounting for currentCalcium is a versatile multitarget intracellular second
observations that it is IP3 receptors rather than ryanodinemessenger found in virtually all cells [19]. Calcium re-
receptors that mediate Ang II-induced calcium release.lease from endoplasmic reticulum occurs through either
The present study provides the first evidence, to ourryanodine or IP3 receptors. In addition to calcium release
knowledge, that TRP-1 proteins exist on glomerular arte-and influx via voltage-dependent calcium channels, ago-
riolar myocytes. Northern blot analysis reveals that iso-nist-induced calcium entry constitutes one of the main
forms of TRP-1, -3 and -6 are expressed in rat kidneyspathways by which cytosolic calcium is regulated [5].
[11]. Of course, our results do not deny the presenceAlthough the nature of voltage-dependent calcium chan-
of the other TRP isoforms. Since TRPs form variousnels is well characterized [13, 22], the precise basis under-
heteromultimers [6, 10], agonist-induced calcium influxlying the receptor-activated calcium entry remains un-
could pass through TRP heteromultimers on efferentclear. Recent studies indicate that the transcripts of TRP
arterioles. Of importance, recent studies showed that thegenes constitute calcium-permeable non-selective cation
TRP-6 isoform consisted of an essential component forchannels as a candidate for receptor-operated calcium
calcium entry in rabbit portal vein upon 1-adrenergicchannels [7, 23].
stimulation [26]. Ang II induces calcium entry throughThere is an emerging consensus on the role of L-type
TRP-3 channels heterologously expressed in Chinesecalcium channels as a mediator of afferent arteriolar
hamster ovary (CHO) cells [8]. The present data usingconstriction by Ang II [1]. Accordingly, the present re-
APB and calcium-free medium indicated that in additionsults are compatible with previous reports [1, 2], and
to IP3CR, calcium entry participated in the Ang II-indicate that calcium entry through L-type calcium chan-
induced efferent arteriolar constriction. Our previousnels mediates sustained afferent arteriolar constriction.
findings demonstrated that Ang II caused calcium entryUnder the blockade of voltage-dependent calcium chan-
in efferent arterioles pretreated with thapsigargin [4],nels, Ang II elicits transient afferent arteriolar constric-
which suggests that Ang II-induced calcium influx intotion. Ang II did not induce either transient or sustained
efferent arterioles involves channels other than store-constriction in afferent arterioles treated with APB.
operated calcium channels, because thapsigargin is aThus, our data provide evidence that Ang II-induced
strong stimulus to induce store-operated calcium entry.IP3CR results in transient afferent arteriolar constriction.
APB inhibits store-operated calcium entry as well asAng II provokes membrane depolarization in afferent
IP3CR [17, 27, 28]. Taken together, these observationsarterioles [3]. These results suggest that Ang II-induced
suggest that Ang II-induced calcium entry into efferentIP3CR elicits membrane depolarization and consequent
arterioles occurs independently of IP3CR and store-activation of voltage-dependent calcium channels by ini-
operated calcium entry. Because L-type calcium channelstiating cellular responses, such as the increase in proba-
are not expressed in efferent arterioles [29] and becausebility of chloride channels to be open [16, 24].
Ang II does not evoke membrane depolarization in effer-Mechanisms mediating efferent arteriolar constriction
ent arterioles [3], it is unlikely that voltage-dependentby Ang II appear different from those of afferent arteri-
calcium channels underlie calcium entry in efferent arte-oles. Previous results have demonstrated that both IP3
rioles. The present studies discovered that a combinedand calcium itself induce calcium release through IP3
treatment with APB and SKF eliminated Ang II-inducedand ryanodine receptors, respectively [19]. The present
efferent arteriolar constriction. Thus, our findings areresults that APB attenuated but did not abolish efferent
compatible with those of Loutzenhiser and Loutzenhiserarteriolar constriction suggest that IP3CR contributes to
[30], and provide evidence that SKF antagonizes Angefferent arteriolar constriction. It is interesting that IP3
II-induced calcium influx into efferent arterioles. Fur-receptor shows a bell-shaped calcium sensitivity [25]. In
thermore, SKF inhibits the calcium current through arti-the presence of IP3, IP3 receptor opens at 100 nmol/L of
ficially expressed TRP channels [5, 9, 26]. Our resultscytosolic calcium and closes at 300 nmol/L of calcium.
demonstrated that the IC50 for SKF in reversing Ang II-Thus, a repetitive calcium release would occur through
induced efferent arteriolar constriction was similar toIP3 receptors, and IP3CR acts as calcium-induced cal-
that observed in TRP-transfected human embryonic kid-cium release at a concentration of IP3. Although our
ney (HEK) cells. Collectively, these observations sup-earlier results support the presence of functioning rya-
port the proposal that Ang II opens TRP channels onnodine receptors in glomerular arterioles (abstract; Take-
efferent arterioles, thereby allowing calcium entry.naka, et al, J Am Soc Nephrol 10:388A, 1999), ryanodine
A caveat is in order. Recent issues have been whetherreceptors play a small role in the arteriolar constriction
some members of the TRP family form capacitative cal-by Ang II. IP3 greatly enhances calcium sensitivity of IP3
cium entry channels activated by depletion of internalreceptors to release calcium [25]. Since Ang II elevates
calcium stores [6, 10]. Store-sensitivity of transfectedthe IP3 level in glomerular arterioles (abstract; McArdle
et al, J Am Soc Nephrol 5:586, 1994), IP3 receptors should TRP channels seems to depend on host cells. Indeed,
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